Skip to main content
. 2020 Feb 13;21(4):1247. doi: 10.3390/ijms21041247

Figure 2.

Figure 2

Evolution of gammaglobulin level before and after GD treatment. Treatment included enzyme replacement therapy or substrate reduction therapy. Slopes were obtained with linear/logarithmic mixed models on patients who received treatment, at two periods: before and after starting treatment. The impact of the treatment was assessed by using an interaction term between period and time.